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Abstract 
Review on IL17F, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: CANDF6, IL-17F, ML-1, ML1 
HGNC (Hugo): IL17F 
Location: 6p12.2 
Local order: Centromere - PKHD1 (polycystic 
kidney and hepatic diseases 1) - MIR206 
(microRNA 206) - MIR133B (microRNA 133b) - 
IL17A (interleukin 17) - IL17F - SLC25A20P1 
(solute carrier family 25, member 20 pseudogene 1) 
- MCM3 (minichromosome maintenance complex 
component 3) - Telomere. 
DNA/RNA 
Description 
The gene spans a region of 7857 bases and the 
coding part is divided into three exons. 
Transcription 
The 492-nucleotide transcript encodes a protein of 
163 amino acid residues. The first and last exons 
are partially untranslated. 
Pseudogene 
None described so far. 
 
 
IL17F gene. The IL17F gene spans a region of 7.86 kb composed of the three exons (untranslated region (UTR), light blue; 
coding region, red) and two introns (green). Exons 1, 2, and 3 are 141 bp (108 bp 5' UTR plus 33 bp coding region), 221 bp (all 
coding region), and 488 bp (238 bp coding region plus 250 bp 3' UTR) in length, respectively. The two introns are 5446 bp and 
1561 bp in length, respectively. 
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IL-17F protein. IL-17F protein (163 amino acids) is composed of a signal peptide (orange, 30 amino acids) and a mature peptide 
(blue, 133 amino acids). Four conserved cysteine residues form intra-chain disulfide bonds (Cys102/Cys152 and 
Cys107/Cys154). Other two cysteines (Cys47 and Cys137) participate in homodimer formation via inter-chain disulfide bonds 
(Hymowitz et al., 2001). There is an intersubunit disulfide linkage between Cys47 from IL-17F and Cys129 from IL-17A. The 





Each IL-17F monomer forms homodimer with 
another IL-17F or heteromer with IL-17A (Chang 
and Dong, 2007; Wright et al., 2007). 
Calculated molecular weight of IL-17F monomer is 
a 15-kD. In non-reducing SDS-PAGE gel, IL-17F 
homodimer runs between 35 to 50kD depending on 
the level of glycosylation (Wright et al., 2007). 
Expression 
Compared to IL-17 expression, IL-17F was 
detected more broadly in different tissues 
(Kawaguchi et al., 2001). In lymphoid lineages, IL-
17F expression is tightly regulated. Results from 
IL-17FRFP reporter mouse or intracellular cytokine 
staining of IL-17F indicate that differentiated CD4 
helper T cell Th17 cells, lamina propria CD4 T 
cells, memory CD4 T cells, γδ T cells, iNKT cells, 
and innate lymphoid cells (ILC3) produce IL-17F 
(Cua and Tato, 2010; Pantelyushin et al., 2012; 
Yang et al., 2008b). Regulation of IL-17F closely 
resembles its homologous protein IL-17A. In 
addition to TCR stimulation, TGFβ, IL-6, IL-23 and 
IL-1β are necessary to shape naïve CD4 T cells to 
Th17 cells. Transcription factors STAT3 and 
RORγτ are essential for production of IL-17F as 
well as IL-17 (Martinez et al., 2008; Peters et al.,
2011; Zhou and Littman, 2009). IL-17F expression 
by either ILC3 or γδ T is induced by IL-1β or IL-23 
(Geremia et al., 2011; Sutton et al., 2009). While 
IL-17A production from iNKT cells is independent 
from IL-6 (Doisne et al., 2009) and required TGFβ 
and IL-1β (Monteiro et al., 2013), it is not clear 
whether IL-17F expression is regulated by the same 
cytokines in iNKT cells. 
Distinctive regulatory pathways of IL-17F have 
been reported. Itk-mediated activation of NFATc1 
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upon TCR stimulation induces IL-17A but not IL-
17F (Gomez-Rodriguez et al., 2009).  
Conserved noncoding sites (CNS)2 in the Il17-Il17f 
locus is required for IL-17A expression but 
partially required for IL-17F expression, indicating 
other regulatory elements are involved in the 
regulation of IL-17F expression (Wang et al., 
2012).  
While signaling pathways or transcription factors 
governing γδ T cells (Korn and Petermann, 2012) 
or iNKT cells producing IL-17A (Engel et al., 
2012; Watarai et al., 2012) were reported before, 
the specific regulatory pathways of IL-17F in these 
innate cells remain elusive. 
IL-17A production is restricted to lymphoid 
lineages but IL-17F was reported to be expressed 
by non-lymphoid cells that do not express IL-17A, 
such as human colonic epithelial cells (Tong et al., 
2012).  
IL-17F is produced by non-T, non-B innate immune 
cells and mouse colonic epithelial cells in response 
to infection with C. rodentium (Ishigame et al., 
2009).  
IL-17F is predominantly expressed in bronchial 
epithelial cells in addition to the infiltrating 
inflammatory cells upon asthma induction (Suzuki 
et al., 2007). 
Localisation 
IL-17F is a secreted protein. 
Function 
IL-17F exerts its biological effects through the IL-
17RA/RC signaling complex. While the expression 
of IL-17RA is universal, IL-17RC expression is 
largely restricted to epithelial cells, fibroblasts and 
other stromal cells.  
IL-17RA/RC complex recruits an adaptor molecule, 
Act1, for signaling (Chang et al., 2006; Qian et al.,
2007). Upon binding IL-17F, IL-17RA/RC can 
activate NF-kB and MAPK pathways. IL-17F 
shares the receptor complex with IL-17A 
homodimer and IL-17A/F heterodimer.  
They do not compete for the binding to the receptor 
complex since these cytokines together in the 
culture resulted in additive effects on production of 
pro-inflammatory molecules.  
Binding affinity of IL-17F to IL-17RA is weaker 
compared to IL-17F binding to IL-17RC (Kuestner 
et al., 2007).  
A crystal structure revealed that IL-17RA bound to 
IL-17F in a 1:2 stoichiometry and IL-17RA - IL-
17F complex prefers to form heterodimers with a 
second receptor, IL-17RC, possibly due to steric 
hindrance (Ely et al., 2009). 
Homology 




Familial chronic mucocutaneous candidiasis-6 
(CANDF6) is caused by heterozygous ser65-to-leu 
mutation in the IL17F gene (Puel et al., 2011). 
Chronic mucocutaneous candidiasis (CMC) is 
characterized by infections of the skin, nails, and 
oral and genital mucosae with Candida albicans, 
which is commensal in healthy individuals. S65L 
IL-17F behaves dominant-negative IL17F allele, 
which impairs the receptor binding and bioactivity 
of both IL-17F homodimers and IL-17A - IL-17F 
heterodimers. 
A coding region variant (His161Arg) of IL-17F 
gene, possibly encoding an antagonist for IL-17F, 
has been linked to asthma patients in Japanese 
populations (Kawaguchi et al., 2006). 
Implicated in 
Host defense against infections 
Note 
IL-17F expression has been detected in various 
types of infections.  
So far, IL-17F has been mainly involved in mucosal 
host defense mechanisms.  
IL-17F deficient mice are susceptible in C. 
rodentium infection and defective in producing β 
defensin during the infection (Ishigame et al., 
2009).  
IL-17F is also required to protect the mice against 




In acute colitis model using dextran sulfate sodium, 
IL-17F deficiency resulted in reduced colitis 
symptoms (Yang et al., 2008a).  
This phenotype is opposite to IL-17 deficiency, 
where IL-17 knockout mice developed more severe 
colitis.  
However, in chronic colitis using CD4 transfer 
system, pathology was mediated by redundant 
effects of IL-17A and IL-17F (Leppkes et al., 
2009), suggesting therapeutic blocking of both IL-
17A and IL-17F is likely to be required to suppress 
the inflammation in colon. 
Colon cancer 
Note 
IL-17F deficiency resulted in increased colonic 
tumor numbers. IL-17F is expressed in normal 
human colonic epithelial cells, but this expression is 
greatly decreased in colon cancer tissues in this 
study (Tong et al., 2012). 
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Autoimmune diseases 
Note 
In experimental autoimmune encephalitis, IL-17F is 
not required for the initiation of the disease (Yang 
et al., 2008a) and may play a redundant role in 
promoting inflammation (Haak et al., 2009). IL-17F 
is not required to induce inflammation either in 
collagen induced arthritis model, or arthritis model 
using IL-1rn deficient mice (Ishigame et al., 2009). 
Lung inflammations 
Note 
IL-17F has been detected in the lungs from asthma 
and COPD. IL-17F was detected in BALF of 
allergic patients (Kawaguchi et al., 2001) or 
bronchial epithelial cells after asthma induction 
(Suzuki et al., 2007). The role of IL-17F in allergic 
asthma has been argued. While several studies have 
shown that IL-17A and IL-17F are dispensable or 
negative regulator in eosinophilia of allergic asthma 
(Schnyder-Candrian et al., 2006; Suzukawa et al., 
2012), asthmatic inflammation is heterogeneous. 
Steroid-resistant airway inflammation, airway 
remodeling, or airway hyperreactivity during 
asthmatic inflammation were reported to be 
dependent on Th17 or IL-17A (Kudo et al., 2012; 
Lajoie et al., 2010; McKinley et al., 2008; 
Pichavant et al., 2008). IL-17F, on the other hand, 
was required for neutrophil recruitment upon acute 
allergen challenge (Yang et al., 2008a). 
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